vs

Side-by-side financial comparison of Chemours Co (CC) and DILLARD'S, INC. (DDS). Click either name above to swap in a different company.

DILLARD'S, INC. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Chemours Co). DILLARD'S, INC. runs the higher net margin — 8.8% vs -3.5%, a 12.4% gap on every dollar of revenue. On growth, DILLARD'S, INC. posted the faster year-over-year revenue change (2.9% vs -2.1%). DILLARD'S, INC. produced more free cash flow last quarter ($156.2M vs $92.0M). Over the past eight quarters, Chemours Co's revenue compounded faster (-1.2% CAGR vs -16.9%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

CC vs DDS — Head-to-Head

Bigger by revenue
DDS
DDS
1.1× larger
DDS
$1.5B
$1.3B
CC
Growing faster (revenue YoY)
DDS
DDS
+5.0% gap
DDS
2.9%
-2.1%
CC
Higher net margin
DDS
DDS
12.4% more per $
DDS
8.8%
-3.5%
CC
More free cash flow
DDS
DDS
$64.2M more FCF
DDS
$156.2M
$92.0M
CC
Faster 2-yr revenue CAGR
CC
CC
Annualised
CC
-1.2%
-16.9%
DDS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CC
CC
DDS
DDS
Revenue
$1.3B
$1.5B
Net Profit
$-47.0M
$129.8M
Gross Margin
11.7%
43.4%
Operating Margin
11.5%
Net Margin
-3.5%
8.8%
Revenue YoY
-2.1%
2.9%
Net Profit YoY
-261.5%
4.2%
EPS (diluted)
$-0.32
$8.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
DDS
DDS
Q4 25
$1.3B
$1.5B
Q3 25
$1.5B
$1.5B
Q2 25
$1.6B
$1.5B
Q1 25
$1.4B
$2.0B
Q4 24
$1.4B
$1.4B
Q3 24
$1.5B
$1.5B
Q2 24
$1.6B
$1.5B
Q1 24
$1.4B
$2.1B
Net Profit
CC
CC
DDS
DDS
Q4 25
$-47.0M
$129.8M
Q3 25
$46.0M
$72.8M
Q2 25
$-380.0M
$163.8M
Q1 25
$-5.0M
$214.4M
Q4 24
$-13.0M
$124.6M
Q3 24
$-32.0M
$74.5M
Q2 24
$60.0M
$180.0M
Q1 24
$54.0M
$250.5M
Gross Margin
CC
CC
DDS
DDS
Q4 25
11.7%
43.4%
Q3 25
15.6%
36.6%
Q2 25
17.2%
43.9%
Q1 25
17.3%
34.9%
Q4 24
19.4%
42.6%
Q3 24
19.0%
37.6%
Q2 24
19.8%
44.6%
Q1 24
20.9%
36.6%
Operating Margin
CC
CC
DDS
DDS
Q4 25
11.5%
Q3 25
2.5%
6.2%
Q2 25
-15.4%
14.0%
Q1 25
11.7%
Q4 24
-0.1%
11.4%
Q3 24
-2.1%
6.5%
Q2 24
4.4%
15.2%
Q1 24
5.1%
13.3%
Net Margin
CC
CC
DDS
DDS
Q4 25
-3.5%
8.8%
Q3 25
3.1%
4.8%
Q2 25
-23.5%
10.7%
Q1 25
-0.4%
10.6%
Q4 24
-1.0%
8.7%
Q3 24
-2.1%
5.0%
Q2 24
3.9%
11.6%
Q1 24
4.0%
11.8%
EPS (diluted)
CC
CC
DDS
DDS
Q4 25
$-0.32
$8.31
Q3 25
$0.31
$4.66
Q2 25
$-2.53
$10.39
Q1 25
$-0.03
$13.41
Q4 24
$-0.07
$7.73
Q3 24
$-0.22
$4.59
Q2 24
$0.39
$11.09
Q1 24
$0.36
$15.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
DDS
DDS
Cash + ST InvestmentsLiquidity on hand
$670.0M
$1.1B
Total DebtLower is stronger
$4.1B
Stockholders' EquityBook value
$250.0M
$2.0B
Total Assets
$7.4B
$4.3B
Debt / EquityLower = less leverage
16.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
DDS
DDS
Q4 25
$670.0M
$1.1B
Q3 25
$613.0M
$1.0B
Q2 25
$502.0M
$900.5M
Q1 25
$464.0M
$717.9M
Q4 24
$713.0M
$980.4M
Q3 24
$596.0M
$946.7M
Q2 24
$604.0M
$817.8M
Q1 24
$746.0M
$808.3M
Total Debt
CC
CC
DDS
DDS
Q4 25
$4.1B
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.0B
Q2 24
$4.0B
Q1 24
$4.0B
Stockholders' Equity
CC
CC
DDS
DDS
Q4 25
$250.0M
$2.0B
Q3 25
$274.0M
$1.9B
Q2 25
$228.0M
$1.9B
Q1 25
$566.0M
$1.8B
Q4 24
$571.0M
$2.0B
Q3 24
$643.0M
$1.9B
Q2 24
$714.0M
$1.9B
Q1 24
$753.0M
$1.7B
Total Assets
CC
CC
DDS
DDS
Q4 25
$7.4B
$4.3B
Q3 25
$7.5B
$3.7B
Q2 25
$7.5B
$3.9B
Q1 25
$7.4B
$3.5B
Q4 24
$7.5B
$4.1B
Q3 24
$7.5B
$3.7B
Q2 24
$7.2B
$3.9B
Q1 24
$8.0B
$3.4B
Debt / Equity
CC
CC
DDS
DDS
Q4 25
16.40×
Q3 25
14.96×
Q2 25
17.99×
Q1 25
7.18×
Q4 24
7.11×
Q3 24
6.20×
Q2 24
5.53×
Q1 24
5.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
DDS
DDS
Operating Cash FlowLast quarter
$137.0M
$186.5M
Free Cash FlowOCF − Capex
$92.0M
$156.2M
FCF MarginFCF / Revenue
6.9%
10.6%
Capex IntensityCapex / Revenue
3.4%
2.1%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$51.0M
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
DDS
DDS
Q4 25
$137.0M
$186.5M
Q3 25
$146.0M
$86.8M
Q2 25
$93.0M
$232.6M
Q1 25
$-112.0M
$364.7M
Q4 24
$138.0M
$173.5M
Q3 24
$139.0M
$-68.4M
Q2 24
$-620.0M
$244.4M
Q1 24
$-290.0M
$436.5M
Free Cash Flow
CC
CC
DDS
DDS
Q4 25
$92.0M
$156.2M
Q3 25
$105.0M
$60.1M
Q2 25
$50.0M
$215.8M
Q1 25
$-196.0M
$349.3M
Q4 24
$29.0M
$145.4M
Q3 24
$63.0M
$-94.3M
Q2 24
$-693.0M
$209.2M
Q1 24
$-392.0M
$408.2M
FCF Margin
CC
CC
DDS
DDS
Q4 25
6.9%
10.6%
Q3 25
7.0%
4.0%
Q2 25
3.1%
14.1%
Q1 25
-14.3%
17.3%
Q4 24
2.1%
10.2%
Q3 24
4.2%
-6.3%
Q2 24
-44.6%
13.5%
Q1 24
-28.8%
19.2%
Capex Intensity
CC
CC
DDS
DDS
Q4 25
3.4%
2.1%
Q3 25
2.7%
1.8%
Q2 25
2.7%
1.1%
Q1 25
6.1%
0.8%
Q4 24
8.0%
2.0%
Q3 24
5.0%
1.7%
Q2 24
4.7%
2.3%
Q1 24
7.5%
1.3%
Cash Conversion
CC
CC
DDS
DDS
Q4 25
1.44×
Q3 25
3.17×
1.19×
Q2 25
1.42×
Q1 25
1.70×
Q4 24
1.39×
Q3 24
-0.92×
Q2 24
-10.33×
1.36×
Q1 24
-5.37×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

DDS
DDS

Segment breakdown not available.

Related Comparisons